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Objectives:  Touch imprint cytology (TIC) is a reliable, cost-effective technique for the diagnosis of cancer.
The aim of this study was to determine the diagnostic value and accuracy of TIC of prostate core needle
biopsy (CNB) specimens in predicting the final histology in patients with suspected prostate cancer.
Subjects and  methods:  TIC was carried out on 354 core needle biopsy specimens taken from 59 patients
with suspected prostate cancer as indicated by a high prostate serum antigen (PSA) level or abnormal
findings on rectal examination. All biopsies were taken under transrectal ultrasound (TRUS) guidance. Two
touch imprints were prepared from each CNB. The TIC results were correlated with CNB.
Results: TIC revealed evaluable results in 336/354 (94.9%) CNB specimens analyzed, with the follow-
ing cytological diagnosis: malignancy in 40 (11.9%), atypical features in 47 (14%) and benign results in
249 (74.1%) specimens. Histopathological examination of the 40 CNB specimens showing malignant fea-
tures on TIC confirmed the diagnosis of prostate cancer. In 24/47 (51.1%) cases with atypical cytology,
histopathological assessment of the CNB specimens revealed benign features in 7 and prostatitis in 17, while
high-grade prostatic intraepithelial neoplasia (HGPIN) and carcinoma were seen in 3 and 20 specimens,
respectively. In 12/249 (4.8%) cases showing benign results on TIC, histopathological examination of the
CNB specimens revealed an abnormal histology in the form of HGPIN in 9 (75%) and carcinoma in 3 (25%)
cases. TIC accurately predicted the final histology in 336 cases with a sensitivity of 84% and a specificity
of 90.8%. When excluding atypical cytology on TIC and HGPIN on CNB, the sensitivity and specificity
were 93% and 100%, respectively. A strong correlation was seen between TIC and CNB (p  < 0.001).
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Conclusions:  The routine use of TIC complements CNB reports and helps to provide an immediate and
reliable cytological diagnosis of prostate lesions. TIC and serial sectioning of CNB specimens significantly
improve the diagnostic accuracy.
© 2015 Pan African Urological Surgeons’ Association. Production and hosting by Elsevier B.V. All rights reserved.
Introduction
Prostate cancer is the most common non-cutaneous cancer in men
in the United States with an incidence of 126.1 per 100,000 men
of all races and Hispanic origin, and it is also one of the leading
causes of cancer mortality [1]. An estimated 1 in 6 white men and 1
in 5 African-American men will be diagnosed with prostate cancer
in their lifetime, with the likelihood increasing with age [2]. The
current incidence of carcinoma of the prostate among indigenous
Kuwaitis is 17.8 per 100,000 men per year [3]. The risk of getting
prostate cancer increases with age. According to a recent report, 6.4,
12.6 and 14.9 percent of men sixty years of age in the United States
will develop prostate cancer in 10, 20 and 30 years respectively [4].
The most important tools helping in the early diagnosis of prostate
cancer are the use of prostate – specific antigen (PSA) as a screening
tool and transrectal ultrasound (TRUS) – guided prostate biopsy [5].
The risk of disease increases as the PSA levels increase, however, no
PSA level guarantees the absence of prostate cancer [5]. Diagnosis
relies on TRUS and core needle biopsy (CNB). According to the
usual biopsy protocol, 10–12 core needle biopsy specimens are taken
for systematic mapping of the prostate, including any palpable or
radiological target lesions [5]. However, some studies have revealed
a 20–40% false negative rate of sextant biopsies [6], and it has
been felt that touch imprint cytology (TIC) may provide additional
information to CNB interpretation [7–9]. The aim of this study was
to evaluate the accuracy of TIC in the diagnosis of prostate cancer.
Subjects  and  methods
Over a period of 6 months, TIC was carried out on 354 core needle
biopsy specimens taken from 59 patients with suspected prostate
cancer as indicated by a high PSA level or abnormal findings on
rectal examination. The study was performed according to the guide-
lines of the local ethics committee which conforms to the Helsinki
Declaration. The biopsies were taken under TRUS guidance using
a 17–gauge coaxial introducer and an 18-gauge Tru-cut core biopsy
needle. The median number of CNBs per patient was 12 (range
5–12). According to the study protocol, 10–12 CNBs were to be
taken from each patient, however a smaller number of CNBs was
taken in patients unable to tolerate the procedure. These patients
were normally rescheduled for biopsy under local anesthesia at a
later date.
Two CNB specimens on average were taken from each of the six
sites sampled. As soon as the CNB was obtained, it was care-
fully smeared on the slide by the cytopathologist. The imprint
smears were air-dried and stained using the May–Grünwald–Giemsa
staining method. After preparing the touch imprints, the CNB
specimens were fixed in buffered 10% formaldehyde for further
fixation and staining with hematoxylin and eosin. The CNB speci-
mens were independently and blindly reviewed by an experienced
histopathologist (SH), while TIC was carried out by an experienced
cytopathologist (KK) who categorized the results as benign, atypi-
cal cytology, positive and unsatisfactory. The criteria for a positive
cytology (i.e. malignancy) included nuclear pleomorphism, a high
nuclear cytoplasmic ratio, nuclear molding and prominent nucleoli
with loss of polarity at the edge of clusters in an acinar arrangement
(Fig. 1A and B). TIC was considered benign when mono-layered
sheets of uniformly distributed nuclei with fine chromatin and small
nucleoli were observed (Fig. 1C and D). The cases were labeled as
atypical cytology when the morphologic features were not sufficient
to label the cells as malignant. Finally, the cytological diagnosis
was correlated with the histological diagnosis. To ease the correla-
tion, one morphological diagnosis was taken from each of the two
CNB specimens taken from one site. TIC-positive but histologically
negative biopsies underwent serial sections.
Statistical  analysis
Comparing the results of cytologic and histopathologic examination,
the sensitivity, specificity, positive predictive value and negative pre-
dictive value were calculated. In order to prepare a two-way tables
worksheet for statistical analysis, benign conditions and inflamma-
tion were classified as negative results, while an atypical or positive
TIC was considered as malignant. HGPIN and carcinoma cases
were grouped together in the group of malignant cases for histolog-
ical diagnosis. Patients with non-diagnostic TIC as well as patients
with atypical TIC and HGPIN on CNB were excluded from the
calculations of sensitivity, specificity, positive predictive value and
negative predictive value. The following definitions were used in
this analysis:
Sensitivity: True positive/(True positive + False negative)
Specificity: True negative/(True negative + False positive)
Positive predictive value: True positive/(True positive + False pos-
itive)
Negative predictive value: True negative/(True negative + False
negative).
All statistical calculations were performed using IBM SPSS Statis-
tics 19 for Windows. The Chi-square test was used to assess the
association between the histopathological and cytological tests. Sig-
nificance of the statistical tests was based on a 95% confidence
interval.
Results
The patients’ age ranged from 51 to 83 years with a median age
of 67 years (Table 1). The serum PSA levels were correlated
with the histological diagnosis (Table 2). No significant correlation
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Figure  1  (A) TIC revealing carcinoma of the prostate showing a loose cluster of pleomorphic cells with vesicular nuclei having prominent nucleoli
(May–Grünwald–Giemsa 400×). (B) CNB showing carcinoma (H&E 400×). (C) TIC revealing benign cytology showing a monolayered sheet of
cells with uniform rounded nuclei (May–Grünwald–Giemsa 400×). (D) CNB showing benign prostatic tissue (H&E 200×).
Table  1  Age distribution and histological diagnosis of patients undergoing transrectal ultrasound (TRUS)-guided prostate biopsy.
Age group (years) Number of patients Number of CNB specimens (%) Benign (BPH) Histological diagnosis
Inflammation HGPIN Carcinoma
50–54 6 36 (10.2) 11 12 1 12
55–59 5 30 (8.5) 18 6 2 4
60–64 13 78 (22) 37 30 4 7
65–69 15 90 (25.4) 38 33 1 18
70–74 13 78 (22) 28 27 3 20
75–79 3 18 (5.1) 6 11 1 0
80–84 4 24 (6.8) 11 9 0 4
Total 59 354 149 (42.1) 128 (36.2) 12 (3.3) 65 (18.4)
Values in ( ) indicate percentages; CNB: core needle biopsy; BPH: benign prostatic hyperplasia; HGPIN: high-grade prostate intraepithelial neoplasia.
Table  2  Correlation of serum PSA levels with the histological diagnosis.
Serum PSA (ng/ml) Number of patients Histological diagnosis
Benign (BPH) Inflammation HGPIN Carcinoma
0.2 to <4.0 4 1 1 1 1
4.0 to <10.0 21 3 11 5 2
10 to <20 13 1 7 0 5
≥20 9 1 1 0 7
Not available 12 2 6 1 3
Total 59 8 (13.6) 26 (44.1) 7 (11.8) 18 (30.5)
Values in ( ) indicate percentages; BPH: benign prostatic hyperplasia; HGPIN: high-grade prostate intraepithelial neoplasia; PSA: prostate specific antigen.
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Table  3  Correlation of TIC with histological diagnosis.
TIC Number of CNB specimens (%) Histological diagnosis
Benign Inflammation HGPIN Carcinoma
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TIC: touch imprint cytology; CNB: core needle biopsy; HGPIN: high-grade prostate intraepithelial neoplasia; [ ] % within TIC; ( ) % within histological
diagnosis.
was observed between the serum PSA levels and the histological
diagnosis.
Out of 35 patients with no lesion on TRUS, 24 cases were found to be
benign on CNB and 21 on TIC, while CNB revealed carcinoma/high-
grade prostate intraepithelial neoplasia (HGPIN) in 4 out of 8
patients with a suspicious lesion on TRUS. TIC was abnormal
in 6 of these 8 patients. Benign TRUS findings were seen in 16
patients, but CNB and TIC revealed carcinoma/HGPIN in 10 of
them. Thus, TRUS findings were not found to be a good indicator
for the detection of malignancy.
Of the 354 touch imprints taken from 59 patients, 249 (70.3%)
were diagnosed as benign, 47 (13.3%) as atypical, 40 (11.3%) as
malignant and 18 (5.1%) as unsatisfactory. The 354 CNB specimens
showed benign features in 149 (42.1%), prostatitis in 128 (36.2%),
HGPIN in 12 (3.3%) and carcinoma in 65 (18.4%). The correla-
tion of TIC with the histological diagnosis is shown in Table 3. In
all the 40 cases where TIC had revealed carcinoma, malignancy
was confirmed. Of the 47 cases with atypical cytology on TIC, 20
(42.6%) were found to be carcinoma and 3 (6.4%) were found to be
HGPIN, while 7 (14.8%) were benign cases. Prostatitis was found
in 17 (36.2%). Out of the 249 cases shown to be benign on TIC,
HGPIN was reported in 9 (3.6%) and carcinoma in 3 (1.2%).
In this study, TIC was found to have a sensitivity of 84% and a
specificity of 90.8% with positive and negative predictive values of
72.4% and 95.2%, respectively. However, when atypical cytology
on TIC and HGPIN on CNB were excluded, TIC was found to
have a sensitivity of 93% and a specificity of 100% with positive
and negative predictive values of 100% and 98.8%, respectively. A
strong correlation was seen between TIC and CNB (p  < 0.001).
Discussion
The systematic sextant biopsy scheme recommended by Hodge et al.
has significantly improved detection of prostate carcinoma [10]. For
a higher prostate cancer detection rate, it is recommended to take
10–12 core prostate biopsy specimens. However, as a number of
studies have revealed a 20–40% false negative rate, a repeat biopsy
is suggested in cases with a negative biopsy result [11]. Several
authors have tried to augment the positive biopsy rate by applying
TIC in addition to CNB [6,8,9].
TIC is extremely helpful when evaluating malignancies, and it is
increasingly being used in the evaluation of sentinel lymph node
biopsies in cases of breast carcinoma [12]. When used as an adjunct
to CNB in breast cancer cases, TIC has been found to improve
diagnostic accuracy [13–15]. But TIC has also been helpful in
the diagnosis of gastrointestinal, lung, lymph node and bone mar-
row tumors [8,16]. TIC in combination with CNB is cost effective
and does not add any burden to the patient. The procedure simply
requires applying the tissue sample on a glass slide. It not only helps
to document adequacy of the specimen but also augments the diag-
nosis made on CNB. Tumor cell groups which are less cohesive may
be selectively enriched in the tissue fluid covering the CNB, thus
giving a unique source for cytological analysis [6]. The cytopathol-
ogist can immediately interpret the smears whereas the histological
analysis of the CNB takes a minimum of 24 h [8].
In cases of carcinoma of the prostate TIC has helped to detect
metastases in pelvic lymph nodes [17] and to provide an imme-
diate diagnosis of prostate cancer [9]. TIC has also been found to be
a useful adjunct to CNB, improving the accuracy of the diagnosis of
prostate carcinoma [8]. The very few reports comparing the results
of TIC with the diagnosis provided by CNB evaluation imply that
TIC has a central role in the diagnosis and management of patients
with prostate cancer [8,18]. In their study on 1210 CNB specimens
taken from 121 patients under TRUS guidance, Aytac et al. reported
a sensitivity, specificity, positive predictive value and negative pre-
dictive value of 100%, 98%, 90.2% and 100%, respectively [8].
However, in our study, when excluding atypical cytology on TIC
and HGPIN on CNB, the sensitivity, specificity, positive predictive
value and negative predictive value were 93%, 100%, 100% and
98.8%, respectively. In 24 cases showing atypical cytology on TIC,
CNB showed benign features in 7 and prostatitis in 17. It is well
known that inflammation can produce moderate to severe atypia of
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the prostatic glands. Cancer was confirmed in all cases that were
positive for malignancy on TIC.
In 10 out of 20 false-positive cases, Aytac et al. found that reactive
atypia due to dense neutrophil infiltration caused the over diagno-
sis, while in the remaining 10 cases they failed to detect cancer in
the CNB in spite of deep sectioning [8]. Lane et al. [19] demon-
strated the necessity of cutting at least three levels of the prostate
biopsy cylinder. In their study, sampling the cylinder at only one
level missed an average of 23.4% of the total biopsy length, while
sampling the tissue at three levels only missed an average of 7%.
In our study, 12 cases were found to be benign on TIC, whereas
on CNB 9 of them turned out to be HGPIN and 3 carcinomas. The
possible reasons for this discrepancy could be necrosis or very scanty
tumor cells as is expected in cases of HGPIN.
In conclusion, our study reinforces that TIC is a reliable, easy
method for the evaluation of prostate carcinoma in conjunction with
PSA level assessment and TRUS-guided CNB.
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